Florbetapir
- 1 lab in 1 country
- Humans2
- In silico1
Upstream
1Deepsuvr
upin humans1
1 study
Deepsuvr
upin humans1
Deepsuvr improves florbetapir in humans.
“AI correction of CL with the DeepSUVR method significantly improves the performance of Florbetapir”
Humansn = 150
AAIC 2025 abstract23 Dec 2025
Latest
62 in 12 monthsJournal of Alzheimer's Disease
Greater amyloid burden in cognitive networks in preclinical Alzheimer's disease
Cross-sectional study of 157 peopleBiomarkers
Molecular Imaging and Biology
Hybrid CNN-Transformer Framework for Molecular Imaging-based Early Alzheimer's Disease Detection
Computational studyAlzheimer's disease
Journal of Alzheimer's Disease
APOE4 moderates the association of sleep disturbance with cerebral amyloid burden but not with clinical conversion in cognitively normal older adults
Cohort study of 301 peoplePopulations
Journal of Alzheimer's Disease
Comparison of baseline characteristics between cognitively normal and mild cognitive impairment and association of white matter hyperintensity trajectories with diagnostic outcomes, cognition, and amyloid-β protein: A longitudinal study
Cohort study of 857 peopleMild cognitive impairment
bioRxiv
Cognitive Fitness in Ageing (COFITAGE): A Multimodal and Longitudinal Neuroimaging Dataset
Preprint: cohort study of 101 peopleAI & data
Alzheimer's & Dementia
Cerebral amyloid associated with global cognition is differentially moderated by pulse pressure across education levels in The 90+ Study
Cohort study of 296 peoplePopulations
medRxiv
Amyloid-PET pipeline choice influences classification of preclinical Alzheimers disease
Preprint: cohort study of 433 peopleAmyloid PET
Alzheimer's & Dementia
Parallel neuroinflammatory pathways to cerebrovascular burden and amyloid beta in Alzheimer's disease
Cohort study of 126 peopleInflammation
AAIC 2025 Abstract
Prognostic utility of p ‐tau217 and tau PET in Alzheimer's disease
Cohort study of 156 peopleTau PET